Associations of Growth Hormone (GH) Mediators with Loss of Glycemic Control in Youth with Type 2 Diabetes (T2D)

被引：0
|
作者：
Lu, Chang
Wolfs, Danielle
El Ghormli, Laure
Laffel, Lori M.
Patti, Mary-Elizabeth
Isganaitis, Elvira M.
机构：
来源：
DIABETES | 2023年 / 72卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.2337/db23-134-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
134-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Plasma Metabolites Predict Loss of Glycemic Control in Youth with Type 2 Diabetes (T2D)
    Bjornstad, Petter
    Vigers, Timothy B.
    De Boer, Ian
    El Ghormli, Laure
    Heerspink, Hiddo L.
    Laffel, Lori M.
    Ryder, Justin R.
    Shah, Amy S.
    Lynch, Jane L.
    Gubitosi-Klug, Rose
    Drews, Kimberly
    Tommerdahl, Kalie L.
    Tryggestad, Jeanie B.
    Isganaitis, Elvira M.
    Bacha, Fida
    Pyle, Laura
    Sharma, Kumar
    DIABETES, 2023, 72
  • [2] Circulating Metabolomic Biomarkers of Glycemic Control in Youth with Type 2 Diabetes (T2D)
    Chen, Zsu-Zsu
    Lu, Chang
    Shi, Xu
    Zheng, Shuning
    Wolfs, Danielle
    Bjornstad, Petter
    Gerszten, Robert E.
    Isganaitis, Elvira M.
    DIABETES, 2023, 72
  • [3] TRENDS IN GLYCEMIC MEDICATIONS AND CONTROL IN YOUTHS WITH TYPE 2 DIABETES (T2D): THE SEARCH FOR DIABETES IN YOUTH STUDY
    Shankar, R. Ravi
    Pinto, Cathy Anne
    Wang, Tongtong
    Stafford, Jeanette M.
    D'Agostino, Ralph B.
    Lawrence, Jean M.
    Kim, Grace
    Pihoker, Catherine
    Dabelea, Dana
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 16 - 17
  • [4] Trends in Glycemic Medication and Control in Youths with Type 2 Diabetes (T2D): The SEARCH for Diabetes in Youth Study
    Dabelea, Dana
    Pinto, Cathy A.
    Wang, Tongtong
    Shankar, Ravi
    Stafford, Jeanette M.
    D'Agostino, Ralph B., Jr.
    Lawrence, Jean M.
    Kim, Grace
    Pihoker, Catherine
    DIABETES, 2017, 66 : A46 - A46
  • [5] Differential Effects of Type 1 (T1D) and Type 2 Diabetes (T2D) on the Growth Hormone (GH)-Insulin-Like Growth Factor (IGF) Axis in Youth
    Snell-Bergeon, Janet K.
    Reusch, Jane E. B.
    Baumgartner, Amy D.
    Cree-Green, Melanie
    Nadeau, Kristen J.
    DIABETES, 2019, 68
  • [6] The Impact of Electronic Consultation (EC) on Glycemic Control in Type 2 Diabetes (T2D)
    Morariu, Elena M.
    Bandi, Archana
    Derubertis, Frederick
    Rao, R. Harsha
    DIABETES, 2016, 65 : A318 - A318
  • [7] Use of Statins in Patients with Insulin-Treated Type 2 Diabetes (T2D): Associations with Glycemic Control and Mortality Risks
    Anyanwagu, Uchenna C.
    Mamza, Jil B.
    Idris, Iskandar
    Donnelly, Richard
    DIABETES, 2017, 66 : A433 - A433
  • [8] Characteristics Associated with Glycemic Control in Adults with Type 2 Diabetes (T2D) Initiating Incretin Therapies
    Mehta, Sanjeev N.
    Mcmullen, William
    Niewczas, Monika A.
    Gruener, Alf
    Doria, Alessandro
    DIABETES, 2015, 64 : A298 - A298
  • [9] Glycemic Control and Adherence to Basal Insulin Therapy in Taiwanese Patients with Type 2 Diabetes (T2D)
    Chien, Ming-Nan
    Chen, Yen-Ling
    Hung, Yi-Jen
    Wang, Shu-Yi
    Lu, Wen-Tsung
    Chen, Chih-Hung
    Lin, Ching-Ling
    Huang, Tze-Pao
    Tsai, Ming-Han
    Tseng, Wei-Kung
    Wu, Ta-Jen
    Ho, Cheng
    Lin, Wen-Yu
    Chen, Bill
    Chuang, Lee-Ming
    DIABETES, 2014, 63 : A600 - A600
  • [10] Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes (T2D)
    Grunberger, G
    Weston, WM
    Patwardhan, R
    Rappaport, EB
    DIABETES, 1999, 48 : A102 - A102
12345